サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1625408

パラセタモール静注市場、規模、シェア、動向、産業分析レポート：適応症別、用途別、最終用途別、地域別 - 市場予測、2025年～2034年

Paracetamol IV Market Size, Share, Trends, Industry Analysis Report: By Indication (Pain and Pyrexia), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034

出版日
ページ情報
英文 128 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
パラセタモール静注市場、規模、シェア、動向、産業分析レポート：適応症別、用途別、最終用途別、地域別 - 市場予測、2025年～2034年
出版日: 2024年12月01日
発行: Polaris Market Research
ページ情報: 英文 128 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、パラセタモール静注の市場規模は2034年までに11億1,785万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

パラセタモール静注市場拡大の原動力となっているのは、効果的な疼痛管理ソリューションに対する需要の高まりであり、特に速やかな発症が重要な臨床現場での需要が高まっています。特に経口投与が困難な患者には、経口投与よりも静脈内投与製剤が好まれることが、市場の需要を大きく支えています。外科手術の増加、術後の疼痛緩和を必要とする慢性疾患の有病率の増加、高齢者人口の増加といった要因が、パラセタモール静注製剤に対するニーズの高まりに寄与しています。ヘルスケアインフラの世界の拡大は、パラセタモール静注市場の成長を大きく後押ししています。

パラセタモール静注市場の展望は紛れもなく明るいものであり、ドラッグデリバリーにおける画期的な技術革新と、パラセタモールの静脈内投与が多様な患者グループにとってより安全で効果的であることを保証する製剤技術の向上が、大きな市場機会をもたらしています。さらに、パラセタモール静注市場の拡大は、業界大手による研究開発への戦略的投資によって支えられています。これらの投資は、副作用を最小限に抑えながら製品の有効性と安全性を最大化することに特化したものであり、疼痛管理プロトコールにおけるより良い選択肢としてのパラセタモール静注製剤の地位を確固たるものにしています。

パラセタモール静注市場レポート・ハイライト

2024年のパラセタモール静注市場では、手術後や外傷後の効果的かつ即時的な鎮痛に対する需要が高いことから、適応症別では疼痛分野が大きなシェアを占めています。

外来診療への嗜好の高まりと、診療所における静脈内疼痛管理オプションの利用可能性の増加により、エンドユースに基づく診療所セグメントは予測期間中に最も高いCAGRを記録すると予想されます。

2024年時点では、北米がパラセタモール静注市場シェアを独占しているが、これは同地域全体で効果的な疼痛管理が重視されているためです。

アジア太平洋市場は、ヘルスケア投資の増加により、予測期間中に大きな成長が見込まれます。

世界の主要市場企業としては、Mallinckrodt（Mallinckrodt Pharmaceuticals）、Cipla Inc.、Lupin、Dr Reddy's Laboratories Ltd.、Aurobindo Pharma、Sun Pharmaceutical Industries Limited、Novartis AG、Pfizer Inc.、Abbott、Sanofi、Bristol-Myers Squibb Companyなどが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のパラセタモール静注市場の洞察

  • 市場スナップショット
  • パラセタモール静注市場力学
    • 促進要因と機会
      • 外科手術の増加
      • 慢性疼痛と発熱の増加
    • 抑制要因と課題
      • 代替薬の選択肢
  • PESTEL分析
  • パラセタモール静注市場動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のパラセタモール静注市場：適応症別

  • 主な調査結果
  • イントロダクション
  • 痛み
  • 発熱

第6章 世界のパラセタモール静注市場：用途別

  • 主な調査結果
  • イントロダクション
  • 外科手術
  • 非外科的

第7章 世界のパラセタモール静注市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • クリニック
  • その他

第8章 世界のパラセタモール静注市場：地域別

  • 主な調査結果
  • イントロダクション
    • パラセタモール静注市場評価：地域別、2020-2034年
  • 北米
    • 北米：適応症別、2020-2034年
    • 北米：用途別、2020-2034年
    • 北米：最終用途別、2020-2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：適応症別、2020-2034年
    • 欧州：用途別、2020-2034年
    • 欧州：最終用途別、2020-2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：適応症別、2020年-2034年
    • アジア太平洋地域：用途別、2020-2034年
    • アジア太平洋地域：最終用途別、2020-2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：適応症別、2020-2034年
    • 中東・アフリカ：用途別、2020-2034年
    • 中東・アフリカ：最終用途別、2020-2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：適応症別、2020-2034年
    • ラテンアメリカ：用途別、2020-2034年
    • ラテンアメリカ：最終用途別、2020-2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Mallinckrodt（Mallinckrodt Pharmaceuticals）
  • Cipla Inc.
  • Lupin
  • Dr Reddy's Laboratories Ltd.
  • Aurobindo Pharma
  • Sun Pharmaceutical Industries Limited
  • Novartis AG
  • Pfizer Inc.
  • Abbott
  • Sanofi
  • Bristol-Myers Squibb Company
図表

List of Tables:

Table 1 Global Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 2 Global Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 3 Global Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 4 North America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 5 North America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 6 North America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 7 U.S.: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 8 U.S.: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 9 U.S.: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 10 Canada: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 11 Canada: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 12 Canada: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 13 Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 14 Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 15 Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 16 UK: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 17 UK: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 18 UK: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 19 France: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 20 France: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 21 France: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 22 Germany: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 23 Germany: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 24 Germany: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 25 Italy: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 26 Italy: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 27 Italy: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 28 Spain: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 29 Spain: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 30 Spain: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 31 Netherlands: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 32 Netherlands: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 33 Netherlands: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 34 Russia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 35 Russia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 36 Russia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 37 Rest of Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 38 Rest of Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 39 Rest of Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 40 Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 41 Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 42 Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 43 China: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 44 China: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 45 China: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 46 India: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 47 India: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 48 India: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 49 Malaysia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 50 Malaysia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 51 Malaysia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 52 Japan: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 53 Japan: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 54 Japan: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 55 Indonesia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 56 Indonesia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 57 Indonesia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 58 South Korea: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 59 South Korea: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 60 South Korea: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 61 Australia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 62 Australia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 63 Australia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 64 Rest of Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 65 Rest of Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 66 Rest of Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 67 Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 68 Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 69 Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 70 Saudi Arabia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 71 Saudi Arabia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 72 Saudi Arabia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 73 UAE: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 74 UAE: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 75 UAE: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 76 Israel: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 77 Israel: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 78 Israel: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 79 South Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 80 South Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 81 South Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 82 Rest of Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 83 Rest of Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 84 Rest of Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 85 Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 86 Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 87 Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 88 Mexico: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 89 Mexico: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 90 Mexico: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 91 Brazil: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 92 Brazil: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 93 Brazil: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 94 Argentina: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 95 Argentina: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 96 Argentina: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 97 Rest of Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 98 Rest of Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 99 Rest of Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

List of Figures:

Figure 1. Global Paracetamol IV Market, 2020-2034 (USD Million)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Indication

Figure 7. Global Paracetamol IV Market, by Indication, 2024 & 2034 (USD Million)

Figure 8. Market by Application

Figure 9. Global Paracetamol IV Market, by Application, 2024 & 2034 (USD Million)

Figure 10. Market by End Use

Figure 11. Global Paracetamol IV Market, by End Use, 2024 & 2034 (USD Million)

目次
Product Code: PM5289

The paracetamol IV market size is expected to reach USD 1,117.85 million by 2034, according to a new study by Polaris Market Research. The report "Paracetamol IV Market Share, Size, Trends, Industry Analysis Report: By Indication (Pain and Pyrexia), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising demand for effective pain management solutions, particularly in clinical settings where rapid onset is crucial, drives the paracetamol IV market expansion. The preference for intravenous (IV) formulations over oral routes, especially for patients unable to take medication orally, significantly supports market demand. Factors such as increasing surgical procedures, a growing prevalence of chronic conditions requiring postoperative pain relief, and the expanding geriatric population contribute to the rising need for paracetamol IV formulations. The global expansion of healthcare infrastructure is significantly propelling the paracetamol IV market growth, as more hospitals and clinics are becoming equipped to provide IV pain management.

The paracetamol IV market outlook is undeniably positive, with significant market opportunities fueled by groundbreaking innovations in drug delivery and enhanced formulation techniques that ensure intravenous (IV) paracetamol is both safer and more effective for diverse patient groups. Furthermore, the IV paracetamol market expansion is supported by strategic investments in research and development from leading industry players. These investments are specifically geared toward maximizing product efficacy and safety while minimizing side effects, firmly establishing IV paracetamol as a better option in pain management protocols.

Paracetamol IV Market Report Highlights

In terms of indication, in 2024, the pain segment accounted for a larger share of the paracetamol IV market revenue due to the high demand for effective and immediate pain relief in post-surgical and trauma cases.

The clinics segment, based on end use, is expected to witness the highest CAGR during the forecast period due to the growing preference for outpatient care and the increasing availability of intravenous pain management options in clinic settings.

In 2024, North America dominated the paracetamol IV market share due to the strong focus on effective pain management practices across the region.

The Asia Pacific market is expected to witness significant growth during the forecast period due to increasing healthcare investments.

A few global key market players are Mallinckrodt (Mallinckrodt Pharmaceuticals), Cipla Inc., Lupin, Dr Reddy's Laboratories Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Limited, Novartis AG, Pfizer Inc., Abbott, Sanofi, and Bristol-Myers Squibb Company.

Polaris Market Research has segmented the paracetamol IV market report on the basis of indication, application, end use, and region:

By Indication Outlook (Revenue, USD Million; 2020-2034)

  • Pain
  • Pyrexia

By Application Outlook (Revenue, USD Million; 2020-2034)

  • Surgical
  • Non-Surgical

By End Use Outlook (Revenue, USD Million; 2020-2034)

  • Hospitals
  • Clinics
  • Others

By Regional Outlook (Revenue, USD Million; 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Paracetamol IV Market Insights

  • 4.1. Paracetamol IV Market - Market Snapshot
  • 4.2. Paracetamol IV Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Surgical Procedures
      • 4.2.1.2. Rising Prevalence of Chronic Pain and Fever
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Alternative Drug Option
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Paracetamol IV Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Paracetamol IV Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
  • 5.3. Pain
    • 5.3.1. Global Paracetamol IV Market, by Pain, by Region, 2020-2034 (USD Million)
  • 5.4. Pyrexia
    • 5.4.1. Global Paracetamol IV Market, by Pyrexia, by Region, 2020-2034 (USD Million)

6. Global Paracetamol IV Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Paracetamol IV Market, by Application, 2020-2034 (USD Million)
  • 6.3. Surgical
    • 6.3.1. Global Paracetamol IV Market, by Surgical, by Region, 2020-2034 (USD Million)
  • 6.4. Non-surgical
    • 6.4.1. Global Paracetamol IV Market, by Non-surgical, by Region, 2020-2034 (USD Million)

7. Global Paracetamol IV Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 7.3. Hospital
    • 7.3.1. Global Paracetamol IV Market, by Hospital, by Region, 2020-2034 (USD Million)
  • 7.4. Clinics
    • 7.4.1. Global Paracetamol IV Market, by Clinics, by Region, 2020-2034 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Paracetamol IV Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Paracetamol IV Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Paracetamol IV Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Paracetamol IV Market - North America
    • 8.3.1. North America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.3.2. North America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.3.3. North America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.3.4. Paracetamol IV Market - U.S.
      • 8.3.4.1. U.S.: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.3.5. Paracetamol IV Market - Canada
      • 8.3.5.1. Canada: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.4. Paracetamol IV Market - Europe
    • 8.4.1. Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.4.2. Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.4.3. Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.4. Paracetamol IV Market - UK
      • 8.4.4.1. UK: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.5. Paracetamol IV Market - France
      • 8.4.5.1. France: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.5.2. France: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.5.3. France: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.6. Paracetamol IV Market - Germany
      • 8.4.6.1. Germany: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.7. Paracetamol IV Market - Italy
      • 8.4.7.1. Italy: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.8. Paracetamol IV Market - Spain
      • 8.4.8.1. Spain: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.9. Paracetamol IV Market - Netherlands
      • 8.4.9.1. Netherlands: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.10. Paracetamol IV Market - Russia
      • 8.4.10.1. Russia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.11. Paracetamol IV Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.5. Paracetamol IV Market - Asia Pacific
    • 8.5.1. Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.4. Paracetamol IV Market - China
      • 8.5.4.1. China: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.4.2. China: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.4.3. China: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.5. Paracetamol IV Market - India
      • 8.5.5.1. India: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.5.2. India: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.5.3. India: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.6. Paracetamol IV Market - Malaysia
      • 8.5.6.1. Malaysia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.7. Paracetamol IV Market - Japan
      • 8.5.7.1. Japan: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.8. Paracetamol IV Market - Indonesia
      • 8.5.8.1. Indonesia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.9. Paracetamol IV Market - South Korea
      • 8.5.9.1. South Korea: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.10. Paracetamol IV Market - Australia
      • 8.5.10.1. Australia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.11. Paracetamol IV Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.6. Paracetamol IV Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.4. Paracetamol IV Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.5. Paracetamol IV Market - UAE
      • 8.6.5.1. UAE: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.6. Paracetamol IV Market - Israel
      • 8.6.6.1. Israel: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.7. Paracetamol IV Market - South Africa
      • 8.6.7.1. South Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.8. Paracetamol IV Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.7. Paracetamol IV Market - Latin America
    • 8.7.1. Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.4. Paracetamol IV Market - Mexico
      • 8.7.4.1. Mexico: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.5. Paracetamol IV Market - Brazil
      • 8.7.5.1. Brazil: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.6. Paracetamol IV Market - Argentina
      • 8.7.6.1. Argentina: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.7. Paracetamol IV Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Mallinckrodt (Mallinckrodt Pharmaceuticals)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Cipla Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Lupin
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dr Reddy's Laboratories Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Aurobindo Pharma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Sun Pharmaceutical Industries Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Novartis AG
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Pfizer Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Abbott
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sanofi
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Bristol-Myers Squibb Company
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development